Skip to main content
. 2009 Feb 12;6:15. doi: 10.1186/1742-4690-6-15

Figure 8.

Figure 8

PSSM score distribution of V3 amino acid sequences from Pt.3. The PSSM score distribution of all variants from CD36- and CD26-provirus detected in Pt.3 at the moment of therapy interruption are shown together with those from CD36- and CD26- captured virus present one month after therapy stop. Vertical orange lines indicate percentiles for predicted co-receptor usage as in Fig. 6.